作者：
Mitchell J,Elliott [1]
;
Karen,Howarth [2]
;
Sasha,Main [3]
;
Jesús,Fuentes Antrás [4]
;
Philippe,Echelard [5]
;
Aaron,Dou [1]
;
Eitan,Amir [6]
;
Michelle B,Nadler [1]
;
Elizabeth,Shah [7]
;
Celeste,Yu [8]
;
Scott,Bratman [7]
;
Taylor,Bird [7]
;
June,Roh [1]
;
Elza C,de Bruin [9]
;
Christopher,Rushton [2]
;
Sofia,Birkeälv [2]
;
Miguel,Alcaide [10]
;
Lucia,Oton [10]
;
Girish,Putcha [2]
;
Samuel,Woodhouse [11]
;
Philippe L,Bedard [1]
;
Lillian L,Siu [1]
;
Hal K,Berman [7]
;
David W,Cescon [7]
作者单位：
University Health Network, Toronto, Ontario, Canada.
[1]
SAGA Dx, Morrisville, North Carolina, United States.
[2]
University of Toronto, Toronto, Ontario, Canada.
[3]
NEXT Oncology, Madrid, Spain.
[4]
Université de Sherbrooke, Sherbrooke, Quebec, Canada.
[5]
Princess Margaret Cancer Centre, Toronto, Canada.
[6]
Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
[7]
Princess Margaret Cancer Centre, Toronto, ON, Canada.
[8]
AstraZeneca (Australia), Cambridge, United Kingdom.
[9]
SAGA Diagnostics AB, Lund, Sweden.
[10]
SAGA Dx, Morrisville, United States.
[11]
DOI
10.1158/1078-0432.CCR-24-3472
PMID
39785866
发布时间
2025-01-09
换一批
换一批
